We are live on ! Find out more
SGMO

SANGAMO THERAPEUTICS INC
SGMO

Delisted

SGMO was delisted on the 4th of May, 2026.

Back to rankings

124 hedge funds and large institutions have $196M invested in SANGAMO THERAPEUTICS INC in 2016 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 44 increasing their positions, 30 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

261% more call options, than puts

Call options by funds: $5.37M | Put options by funds: $1.49M

47% more repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 30

9% less funds holding

Funds holding: 136 → 124 (-12)

27% less capital invested

Capital invested by funds: $268M → $196M (-$71.4M)

48% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 25

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
124
Holders Change
-12
Holders Change %
-8.82%
% of All Funds
3.31%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
13
Increased
44
Reduced
30
Closed
25
Calls
$5.37M
Puts
$1.49M
Net Calls
+$3.88M
Net Calls Change
-$564K

Top Buyers

Rank Fund Capital Flow
1
O
OrbiMed
New York
+$4.23M
2
NI
Numeric Investors
Massachusetts
+$2.74M
3
State Street
State Street
Massachusetts
+$2.64M
4
Renaissance Technologies
Renaissance Technologies
New York
+$2.44M
5
Deutsche Bank
Deutsche Bank
Germany
+$1.51M

Top Sellers

Rank Fund Capital Flow
1
Bank of New York Mellon
Bank of New York Mellon
New York
-$15.4M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$6.74M
3
AC
Ascend Capital
California
-$2.4M
4
SCM
Suffolk Capital Management
New York
-$1.43M
5
RCM
RA Capital Management
Massachusetts
-$1.36M
Name Holding Trade Value Shares
Change 		Change in
Stake
Canada Life
101
Canada Life
Manitoba, Canada
$24K – – –
DADC
102
D.A. Davidson & Co
Montana
$24K +$3.03K +596 +13%
BCMIO
103
Beacon Capital Management Inc (Ohio)
Ohio
$23K – – –
US Bancorp
104
US Bancorp
Minnesota
$23K – – –
VCM
105
Vigilant Capital Management
Maine
$23K – – –
BNP Paribas Financial Markets
106
BNP Paribas Financial Markets
France
$22.2K +$10.5K +2,064 +76%
LTFS
107
Ladenburg Thalmann Financial Services
Florida
$21K – – –
ACS
108
Archford Capital Strategies
Illinois
$20K – – –
NCM
109
Nelson Capital Management
California
$16K – – –
Nisa Investment Advisors
110
Nisa Investment Advisors
Missouri
$12K -$248K -48,700 -95%
Zurich Cantonal Bank
111
Zurich Cantonal Bank
Switzerland
$11K – – –
BWP
112
Baldwin Wealth Partners
Massachusetts
$7K – – –
Creative Planning
113
Creative Planning
Kansas
$7K +$7.63K +1,500 New
VOYA Investment Management
114
VOYA Investment Management
Georgia
$6.28K +$882K +173,325 +15%
SIM
115
Sonora Investment Management
Arizona
$6.02K – – –
AF
116
Allworth Financial
California
$5K – – –
BKA
117
Brick & Kyle Associates
Pennsylvania
$5K – – –
MFS
118
MSI Financial Services
Massachusetts
$3K -$1.53K -300 -30%
WIC
119
Woodmont Investment Counsel
Tennessee
$3K +$3.43K +675 New
Fifth Third Bancorp
120
Fifth Third Bancorp
Ohio
$2K – – –
TCIM
121
TIAA CREF Investment Management
New York
$1.39K -$89.2K -17,530 -6%
ASN
122
Advisory Services Network
Georgia
$1K – – –
Bank of Montreal
123
Bank of Montreal
Ontario, Canada
$1K – – –
PA
124
Perceptive Advisors
New York
$1K +$1.38K +272 New
AC
125
Ascend Capital
California
– -$2.4M -415,016 Closed
2 3 4
5
6

SGMO Hedge Fund Activity: Q3 2016 in Review

124 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in SANGAMO THERAPEUTICS INC (SGMO) for Q3 2016, worth a combined $196M — down 27% from $268M a quarter earlier.

Sellers outnumbered buyers: 25 funds closed out of SGMO and 13 opened new positions — a net loss of 12 holders — while 30 trimmed existing stakes and 44 added.

The largest buyer was OrbiMed, opening a new position worth an estimated $4.23M. The largest seller was Bank of New York Mellon, cutting an estimated $15.4M.

  • 124 institutional investors held SANGAMO THERAPEUTICS INC (SGMO) as of Q3 2016, down from 136 in Q2 2016.
  • Funds reported $196M of SANGAMO THERAPEUTICS INC stock for Q3 2016, down 27% quarter-over-quarter.
  • 13 funds opened new SANGAMO THERAPEUTICS INC positions in Q3 2016 and 25 closed out, a net change of -12 holders.
  • The largest SANGAMO THERAPEUTICS INC buyer in Q3 2016 was OrbiMed, an estimated $4.23M added.
  • The largest SANGAMO THERAPEUTICS INC seller in Q3 2016 was Bank of New York Mellon, an estimated $15.4M sold.

Based on aggregated 13F filings for Q3 2016.